You are currently viewing a new version of our website. To view the old version click .

Natural Products and Their Modifications as Agents Used in the Fight Against Pathogens, 2nd Edition

This special issue belongs to the section “Natural Products“.

Special Issue Information

Dear Colleagues,

The issue of bacterial strains’ resistance to commercially available antibiotics keeps clinicians around the world up at night. The search for new compounds of natural origin is therefore crucial in solving this issue. It is imperative that such products simultaneously protect the intestinal microbiota, which plays a vital role in maintaining overall bodily health.     

Various extracts of natural origin show biological activity at different levels and simultaneously exert a protective effect on the intestinal microbiota. It is important to choose such chemical modifications that concurrently increase antimicrobial activity, support our immune system, and possess anti-inflammatory and anti-proliferative properties.               

Of particular interest to this Special Issue are articles that compare the biological activity of pathogenic strains and/or intestinal microbiota in the presence of natural compounds/compounds used in medicine in various chemical modifications. Manuscripts examining the effect of plant extracts themselves and pure compounds or their combinations dominant in plants are also of interest.              

Extracts and their main components obtained as a result of chemical modifications and biotransformations appear to be the future in the fight against infections caused by multidrug-resistant strains.

Dr. Anna Duda-Madej
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 250 words) can be sent to the Editorial Office for assessment.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • plant extract
  • natural compounds
  • multidrug-resistant strains
  • intestinal microbiota
  • chemical modyfication
  • biotransformation

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Published Papers

Get Alerted

Add your email address to receive forthcoming issues of this journal.

XFacebookLinkedIn
Pharmaceuticals - ISSN 1424-8247